Nguyen, HaiThuy N. http://orcid.org/0000-0002-4711-9928
McBee, Morgan P. http://orcid.org/0000-0002-7778-4152
Morin, Cara E. http://orcid.org/0000-0003-1953-4486
Sharma, Akshay http://orcid.org/0000-0003-3281-2081
Patel, Kalyani R. http://orcid.org/0000-0003-2654-5386
Silva-Carmona, Manuel http://orcid.org/0000-0002-4908-8301
Guillerman, R. Paul http://orcid.org/0000-0001-8149-613X
Article History
Received: 13 December 2021
Revised: 31 March 2022
Accepted: 3 May 2022
First Online: 14 June 2022
Declarations
:
: Akshay Sharma is the St. Jude Children’s Research Hospital site principal investigator of clinical trials for genome editing of sickle cell disease sponsored by Vertex Pharmaceuticals/CRISPR Therapeutics (NCT03745287) and by Novartis (NCT04443907). The industry sponsors provide funding for the clinical trial, which includes salary support paid to Dr. Sharma’s institution. These disclosures are not directly related to the content in this manuscript. Dr. Sharma acknowledges support from the American Society of Hematology (ASH) Scholar Award. The other authors report no conflicts.